Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 01.11.2024       Telefonica Deutschland Holding AG

Company Name: Telefonica Deutschland Holding AG ISIN: DE000A1J5RX9   Reason for the research: Special situation Recommendation: Buy from: 23.10.2024 Target price: €3.00 Target price on sight of: 12 months Last rating change: - Analyst: Kevin Sheil First Berlin Equity Research has published a correction of the research updat [ … ]
Wed, 30.10.2024       Verve Group SE

Company Name: Verve Group SE ISIN: SE0018538068   Reason for the research: vorläufige Q3-Kennzahlen Recommendation: Kaufen from: 30.10.2024 Target price: €5,40 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE [ … ]
Tue, 29.10.2024       Pharming Group NV

Company Name: Pharming Group NV ISIN: NL0010391025   Reason for the research: Q3/24 results Recommendation: Buy from: 29.10.2024 Target price: €1.70 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010 [ … ]
Tue, 29.10.2024       Knaus Tabbert AG

Company Name: Knaus Tabbert AG ISIN: DE000A2YN504   Reason for the research: Update Recommendation: Kaufen from: 29.10.2024 Target price: €54 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) verö [ … ]
Mon, 28.10.2024       Cardiol Therapeutics Inc

Company Name: Cardiol Therapeutics Inc ISIN: CA14161Y2006   Reason for the research: Update Recommendation: Buy from: 28.10.2024 Target price: USD8.50 Target price on sight of: 12 months Last rating change: - Analyst: Christian Orquera First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (ISI [ … ]
Wed, 23.10.2024       Telefonica Deutschland Holding AG

Company Name: Telefonica Deutschland Holding AG ISIN: DE000A1J5RX9   Reason for the research: Special Situation Recommendation: Buy from: 23.10.2024 Target price: €3.00 Target price on sight of: 12 months Last rating change: - Analyst: Kevin Sheil First Berlin Equity Research on 23.10.2024 initiated coverage on Telefonica D [ … ]
Tue, 16.07.2024       ad pepper media International N.V.

First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 2,90. Zusammenfassung: Trotz geringerer Q2-Umsätze (-3% J/J) verbesserte sich das EBITDA deutlic [ … ]
Mon, 15.07.2024       Knaus Tabbert AG

First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 86,00. Zusammenfassung: Zu Beginn der Q2-Berichtsaison veröffentlichen wir eine Reihe von sommerlichen Wegweisern und Überl [ … ]
Wed, 03.07.2024       Energiekontor AG

First Berlin Equity Research hat ein Research Update zu Energiekontor AG (ISIN: DE0005313506) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 126,00. Zusammenfassung: In den letzten Wochen ist der Aktienkurs von Energiekontor um fast 20% gesunken, da sich das S [ … ]
Mon, 24.06.2024       APONTIS PHARMA AG

First Berlin Equity Research on 24/06/2024 initiated coverage on APONTIS PHARMA AG (ISIN: DE000A3CMGM5/ Bloomberg: APPH GR). Analyst Christian Orquera placed a BUY rating on the stock, with a EUR 17.00 price target. Abstract: Apontis Pharma AG (Apontis) is a leading specialty pharmaceutical company focusing on the development and marketing of a [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 01.04.2025, Calendar Week 14, 91st day of the year, 274 days remaining until EoY.